Systematic review / meta-analysis / 2023
Bariatric surgery was associated with lower risks of overall cancer, obesity-related cancer, and cancer mortality compared to conventional management.
A systematic review and meta-analysis of 32 studies evaluated future cancer risk in patients with obesity receiving bariatric surgery versus conventional treatment. Bariatric surgery was associated with reduced overall cancer incidence (RR 0.62, 95% CI 0.46-0.84, p < 0.002), obesity-related cancer (RR 0.59, 95% CI 0.39-0.90, p = 0.01), and cancer-associated mortality (RR 0.51, 95% CI 0.42-0.62, p < 0.00001). Risk reductions were also seen for hepatocellular, colorectal, pancreatic, gallbladder, breast, endometrial, and ovarian cancers. No significant risk reduction was observed for oesophageal, gastric, thyroid, kidney, prostate cancer, or multiple myeloma.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis
- Who was studied
- Patients with obesity from 32 studies receiving bariatric surgery or conventional treatment
- What was measured
- Future overall cancer incidence, obesity-related cancer incidence, cancer-associated mortality, and specific cancer types
THE PAPER
Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk.
Wilson RB, Lathigara D, Kaushal D. Int J Mol Sci, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.